Top Markets
#1 Nesa Nesa +796.23%
#2 Cortex Cortex +68.84%
#3 Merlin's Seal BTC Merlin's Seal BTC +45.98%
#4 Pons Pons +26.01%
#5 QuantixAI QuantixAI +23.56%
#6 EXOD EXOD +22.78%
#7 OpenEden OpenEden +16.80%
#8 Instadapp Instadapp +16.15%
#9 Movement Movement +15.14%
#10 Magma Finance Magma Finance +12.75%
Coin of the day
Nesa Nesa
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Shenzhen Salubris Pharmaceuticals Co., Ltd. Shenzhen Salubris Pharmaceuticals Co., Ltd.

Shenzhen Salubris Pharmaceuticals Co., Ltd.

002294
Rang in aandelen #3531
Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris... Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris Pharmaceuticals Co., Ltd. operates across the entire pharmaceutical value chain, from research and development to manufacturing and sales. The company primarily focuses on critical therapeutic areas within China, including cardiovascular, anti-diabetic, anti-cancer, and orthopedic medicine. Its diverse product portfolio features a variety of cardiovascular and cerebrovascular medications, such as allisartan isoproxil and clopidogrel bisulfate tablets, alongside injectable options like bivalirudin. A significant offering is the recombinant SeV-hFGF2/dF Injection, specifically developed for the treatment of diabetic foot disease. Salubris also manufactures anti-tumor and orthopedic drugs. Furthermore, its anti-infective range encompasses numerous injectable antibiotics, including ceftazidime and ceftriaxone sodium, as well as oral preparations such as azithromycin dispersible and levetiracetam tablets. The firm also innovates in biotechnological drugs, developing recombinant proteins and monoclonal antibodies. Complementing its domestic operations, Shenzhen Salubris Pharmaceuticals engages in the import, in-licensing, and out-licensing of medicines, particularly for European markets.
Aandeelprijs
$4.64
Marktkapitalisatie
$5.17B
Verandering (1 dag)
0.22%
Verandering (1 jaar)
-37.54%
Land
CN
Handel Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)

Categorie

Healthcare
Omzet van Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)
Omzet in Aug 2026 TTM: 0
Volgens de laatste financiële rapporten van Shenzhen Salubris Pharmaceuticals Co., Ltd. bedraagt de huidige omzet van het bedrijf (TTM) 0. In 2026 behaalde het bedrijf een omzet van 0 gelijk aan de omzet in het jaar 2026, die 0 bedroeg. De omzet is het totale bedrag aan inkomsten dat een bedrijf genereert door de verkoop van goederen of diensten. In tegenstelling tot de winst worden er geen kosten afgetrokken.
Omzetgeschiedenis van Shenzhen Salubris Pharmaceuticals Co., Ltd. van 2026 tot 2026
Omzet aan het einde van elk jaar
Jaar Omzet Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Omzet van vergelijkbare bedrijven of concurrenten
Bedrijf Omzet Omzetverschil Land
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
 $11.03B -
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
 $34.74B -
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
 - -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
 $20.84B -
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
 - -
CH